Scotiabank lowered the firm’s price target on Docebo (DCBO) to $32 from $35 and keeps an Outperform rating on the shares. The company’s preliminary Q4 results indicate an “impressive” core ARR performance, the analyst tells investors. While the firm anticipates a period of margin digestion, Scotiabank sees the signs of underlying strength and the stock’s attractive valuation as a compelling entry point.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCBO:
- Docebo: Share Buyback, Earnings Outperformance, and Improving Profitability Support Continued Buy Rating
- Docebo Launches US$60 Million Share Buyback and Unveils Strong Q4 2025 Preliminaries With 2026 Guidance
- Docebo raises Q4 revenue view to $62.7M-$63M from $62M-$62.2M, consensus $62.08M
- Docebo price target lowered to $28 from $35 at Cantor Fitzgerald
- Docebo Buys 365Talents to Fuse Skills Intelligence With AI Learning Platform